NCT07114354 · NOT YET RECRUITING
Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease
This trial is testing PDCogniCare, a digital platform designed to catch dementia earlier in people who already have Parkinson's disease. Researchers want to know whether it improves on current diagnostic tools, and what affects its adoption in clinics. This is a Phase NA study, meaning it is evaluating a diagnostic tool rather than a drug or treatment — so it is about detection, not intervention.
You may qualify if
- People living with idiopathic Parkinson's disease, one year or more post-diagnosis, attending Movement Disorder Clinics
You're excluded if
- People with severe Parkinson's disease who aren't able to communicate
- People with comorbid neurological conditions (e.g. Stroke)
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-08-11